When examining the possible association between ZFPM2-AS1 expression levels and the clinical parameters of 50 NSCLC patients, we found that tumor size was significantly positively correlated with ZFPM2-AS1 expression (p = 0.007). The gene discussed is ZFPM2; the disease is neoplasm.